Table 3 Prevalence of chronic diseases in individual patient segments
Variable | Stable Chronic | Complex Chronic without frequent hospital admissions | Complex chronic with frequent hospital admissions | End of Life | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|
N = 177,550 | N = 90,540 | N = 4705 | N = 2955 | ||||||
Number of chronic diseases mean, (SD) | 2.4 | (1.3) | 2.4 | (2.0) | 3.5 | (2.9) | 1.6 | (1.6) | <0.001 |
Chronic Diseasesa | |||||||||
Diabetes without chronic complication (%) | 30,823 | (17.4) | 23,506 | (26.0) | 1622 | (34.5) | 178 | (6.0) | <0.001 |
Hypertension (%) | 62,413 | (35.2) | 39,054 | (43.1) | 2540 | (54.0) | 433 | (14.7) | <0.001 |
Chronic kidney disease without ESRF (%) | 4954 | (2.8) | 6674 | (7.4) | 1341 | (28.5) | 42 | (1.4) | <0.001 |
Asthma (%) | 7041 | (4.0) | 3697 | (4.1) | 246 | (5.2) | 34 | (1.2) | <0.001 |
Hyperlipidemia (%) | 59,426 | (33.5) | 34,951 | (38.6) | 1885 | (40.1) | 219 | (7.4) | <0.001 |
Osteoarthritis (%) | 22,367 | (12.6) | 10,966 | (12.1) | 619 | (13.2) | 98 | (3.3) | <0.001 |
Osteoporosis (%) | 452 | (0.3) | 208 | (0.2) | 2 | (0.0) | 2 | (0.1) | <0.001 |
Benign Prostatic hypertrophy (%) | 1265 | (0.7) | 687 | (0.8) | 28 | (0.6) | 3 | (0.1) | <0.001 |
COPD without cor pulmonale (%) | 3084 | (1.7) | 4154 | (4.6) | 453 | (9.6) | 72 | (2.4) | <0.001 |
Hyperthyroidism (%) | 1720 | (1.0) | 422 | (0.5) | 14 | (0.3) | 2 | (0.1) | <0.001 |
Hypothyroidism (%) | 2915 | (1.6) | 1076 | (1.2) | 45 | (1.0) | 1 | (0.0) | <0.001 |
Diabetes with chronic complications (%) | 0 | (0.0) | 8935 | (9.9) | 450 | (9.6) | 12 | (0.4) | <0.001 |
Stroke (%) | 4737 | (2.7) | 8207 | (9.1) | 680 | (14.5) | 67 | (2.3) | <0.001 |
CKD5 or ESRF (%) | 950 | (0.5) | 3600 | (4.0) | 1241 | (26.4) | 40 | (1.4) | <0.001 |
COPD with cor pulmonale (%) | 2169 | (1.2) | 3763 | (4.2) | 441 | (9.4) | 72 | (2.4) | <0.001 |
Major Depression | 1302 | (0.7) | 5398 | (6.0) | 212 | (4.5) | 22 | (0.7) | <0.001 |
Schizophrenia (%) | 273 | (0.2) | 959 | (1.1) | 50 | (1.1) | 7 | (0.2) | <0.001 |
Dementia (%) | 331 | (0.2) | 671 | (0.7) | 65 | (1.4) | 4 | (0.1) | <0.001 |
Bipolar disorder (%) | 2 | (0.0) | 7 | (0.0) | 0 | (0.0) | 0 | (0.0) | <0.001 |
Collagen Vascular diseases (%) | 107 | (0.1) | 1412 | (1.6) | 128 | (2.7) | 15 | (0.5) | <0.001 |
Anxiety (%) | 693 | (0.4) | 2616 | (2.9) | 53 | (1.1) | 6 | (0.2) | <0.001 |
Parkinson’s disease (%) | 282 | (0.2) | 841 | (0.9) | 62 | (1.3) | 7 | (0.2) | <0.001 |
Epilepsy (%) | 289 | (0.2) | 1801 | (2.0) | 108 | (2.3) | 16 | (0.5) | <0.001 |
Coronary heart disease, myocardial infarction | 10,159 | (5.7) | 19,562 | (21.6) | 1513 | (32.2) | 122 | (4.1) | <0.001 |
Atrial fibrillation (%) | 0 | (0.0) | 718 | (0.8) | 91 | (1.9) | 2 | (0.1) | <0.001 |
Hip fracture (%) | 20 | (0.0) | 12 | (0.0) | 2 | (0.0) | 0 | (0.0) | <0.001 |
Spine fracture (%) | 185 | (0.1) | 827 | (0.9) | 77 | (1.6) | 8 | (0.3) | <0.001 |
Moderate or severe liver disease, Liver cirrhosis | 0 | (0.0) | 2843 | (3.1) | 245 | (5.2) | 34 | (1.2) | <0.001 |
Any malignancy, non metastatic (%) | 0 | (0.0) | 25,630 | (28.3) | 885 | (18.8) | 1915 | (64.8) | <0.001 |
Thromboembolism: prosthetic valve, thrombosis, embolism (%) | 0 | (0.0) | 42 | (0.0) | 12 | (0.3) | 3 | (0.1) | <0.001 |
Pressure Ulcer (%) | 10 | (0.0) | 166 | (0.2) | 29 | (0.6) | 2 | (0.1) | <0.001 |
Heart failure & Fluid overload (%) | 936 | (0.5) | 4880 | (5.4) | 811 | (17.2) | 40 | (1.4) | <0.001 |
Peripheral vascular disease (%) | 655 | (0.4) | 3223 | (3.6) | 372 | (7.9) | 25 | (0.8) | <0.001 |
Metastatic disease (%) | 6 | (0.0) | 181 | (0.2) | 16 | (0.3) | 1151 | (39.0) | <0.001 |